local_hospital

Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaza

Address
lock Available on a paid plan

Magyarországi Református Egyház Bethesda Gyermekkorhaza - Pediatric Neurology & Developmental Disorders Center

Bethesda Children's Hospital is a specialized pediatric research center affiliated with the Reformed Church in Hungary, focusing on advancing treatment options for children and adolescents with complex neurological and developmental disorders. The center demonstrates particular expertise in conducting long-term safety studies and innovative therapeutic trials for pediatric populations with challenging neuropsychiatric conditions.

  • Epilepsy syndromes including Dravet Syndrome, Lennox-Gastaut Syndrome, and focal seizure disorders
  • Autism Spectrum Disorder (ASD) with associated behavioral symptoms, particularly irritability
  • Tourette Syndrome and tic disorders in adolescent and adult populations

The hospital's research portfolio emphasizes both safety and efficacy evaluation of novel pharmaceutical interventions, including studies of next-generation antiepileptic medications such as soticlestat and cenobamate as adjunctive therapies. Their commitment to long-term safety monitoring through open-label extension studies and their focus on pediatric neuropsychopharmacology positions them as a key contributor to improving therapeutic outcomes for children with rare and treatment-resistant neurological conditions.

Site Overview

assignment
10
connected trials
corporate_fare
8
sponsors
science
8
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
10
Total trials linked
Highly Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
8
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +1 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 332 other sites in Hungary

description
Trial volume
10
Outperforms 70% of sites
public
Therapeutic diversity
3areas
Outperforms 67% of sites
groups
Sponsor diversity
8sponsors
Outperforms 72% of sites

Therapeutic Area Benchmark — Hungary

Select a therapeutic area to compare against other sites in Hungary.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Hungary

Market Share

Country: Hungary

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaza

lock Showing 1 of 10 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Atogepant in Pediatric Subjects 6 to 17 years of age with MigraineAbbVie Deutschland GmbH & Co. KGPhase IIIRecruitingDec 2023

IMP list

lock Showing 1 of 8 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Atogepant2Unknown2023-11-082023-12-22

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.